Brainsgate ^{For Profit}

BrainsGate is a medical device company that is developing a novel treatment modality, electrical SPG stimulation, which has shown to increase blood flow to the brain and has broad potential for treating central nervous system disorders. The company is focusing on improving the outcome of patients suffering from ischemic stroke, in a 24-hour window after the onset of symptoms. The website provides information on the company's management team, investors, board of directors, scientific advisors, press releases, and publications. There are also sections dedicated to the company's approach to treating ischemic stroke and vascular dementia, as well as driving directions and contact information.